Huascar Brazoban returns from IL, posts scoreless inning in White Sox win over Tigers

Huascar Brazoban is back on the South Side, and he made his return count. The White Sox activated the right-hander from the 15-day injured list ahead of their game with the Tigers, optioning left-hander Chris Murphy to Triple-A in the corresponding move, per MLB Trade Rumors' Mark Polishuk. Brazoban, who had been sidelined since August 24 with a left lat strain, worked a scoreless inning of relief and was the winning pitcher in Chicago's 8-1 victory.

What happened

Per Polishuk's report, the White Sox reinstated Brazoban from the 15-day IL — where he had landed due to a left lat strain — and sent Murphy to Triple-A to clear the roster spot. The move reunited Chicago with the reliever they reportedly acquired from the Mets at the trade deadline, and Brazoban's first outing back was, by the most important measure, a clean one: no runs allowed, a win attached.

The roster mechanics here are straightforward: September expanded the active roster to 28 players, which gives clubs more flexibility to carry arms, but a corresponding move was still required to keep the 40-man in order. Murphy heads to Triple-A rather than the injured list, which means the White Sox are making a deliberate choice about which arm they want available in what is shaping up to be a meaningful stretch run.

Why it matters

The White Sox, per Polishuk's report, sit a game behind the Guardians for the AL Central lead. That context transforms what might otherwise read as a routine IL reinstatement into something with genuine stakes. Brazoban was reportedly acquired at the trade deadline specifically to help Chicago in situations like this one — a pennant race, late innings, leverage moments — and the left lat strain interrupted that audition at a particularly inconvenient time.

Per the report, there is still time for Brazoban to make an impact and potentially earn a spot on a postseason roster if the White Sox can secure a playoff berth. That conditional framing is worth preserving: nothing about a postseason roster is settled, and Brazoban's path there runs directly through how he performs over the remaining regular-season games. One scoreless inning is a start, not a résumé.

The numbers

The season line tells a complicated story. Per Polishuk's report, Brazoban carries a 5.73 ERA over 11 appearances in a White Sox uniform — a figure that reflects, per the report, a reliever who is wild but generally effective, with walks and home runs doing the most damage during his short stint on the South Side.

The underlying profile, per the report, is of a pitcher whose stuff plays but whose command has not always cooperated. That combination — swing-and-miss potential alongside free passes — is the kind of thing that makes a manager's bullpen card look like a choose-your-own-adventure novel. Whether the time away reset anything mechanically is not something the material addresses; what Polishuk's report does say is that the first outing back produced a zero, and in a one-game-back division race, zeros are the currency that matters.

---

Central subplot: Holderman's wrist complicates Cleveland's bullpen picture

What happened

Colin Holderman, one of Cleveland's more reliable relievers, is not a certainty for the Guardians' stretch run. Per Polishuk's report, Holderman was placed on the 15-day IL on September 4 with right wrist inflammation. He felt discomfort in his wrist during the first game of a minor league rehab assignment on Thursday, received an injection in his wrist the following day, and is expected to resume throwing on Monday, per MLB.com's Tim Stebbins as cited by Polishuk.

Why it matters

The timing is tight. The regular season does not pause for wrist injections, and Holderman's availability for any meaningful late-season role depends on how quickly he responds after resuming throwing. Per the report, there is a potential silver lining: if the Guardians win the division and secure a first-round bye, Holderman would have additional recovery time before postseason play begins. That is a meaningful "if," but it is the kind of scheduling quirk that can turn a borderline situation into a manageable one.

Holderman has been a genuine asset in Cleveland's relief corps this season. Per Polishuk's report, he has posted a 2.73 ERA over 52 2/3 innings — the kind of number that explains why his availability is a real question rather than a footnote. A reliever who works that many innings at that rate is not easily replaced by a phone call to the next name on the depth chart.

---

Central subplot: Braxton Ashcraft's 2026 season is over — and that's the good news

What happened

Braxton Ashcraft told MLB.com's Aiden Stepansky and other reporters that he will not pitch again in 2026. Per Polishuk's report, Ashcraft was placed on the 15-day IL on September 7 with right arm discomfort, and subsequent tests revealed nothing more than fatigue — no structural damage. The Pirates, already eliminated from postseason contention, have no reason to push him back to the mound.

Ashcraft addressed the decision directly in quotes reported by Polishuk. He said that with another week available he would be back on the mound, but with Pittsburgh out of playoff contention, he sees no reason to risk anything for pride alone — and that the objective now is to look ahead to next season. That is a remarkably clear-eyed statement from a pitcher who just completed his first full MLB season, and it reflects an organizational posture that prioritizes the offseason over a handful of September innings that carry no playoff implications.

Why it matters

The absence of structural damage is the headline within the headline. Right arm discomfort in a starting pitcher can mean many things, and the range of outcomes runs from "take a few weeks off" to "see you in eighteen months." Per the report, tests placed Ashcraft firmly in the former category — fatigue, not damage. For a pitcher who just logged 165 1/3 innings in his first full season, that distinction matters enormously heading into the offseason.

The Pirates are 79-77 (.506), sitting third in the NL Central, 19 games back in the division, and eliminated from both the division race and the Wild Card race. There is no competitive argument for running Ashcraft back out there, and the organization appears to have made that calculus quickly and cleanly. The Posterior Wire noted Ashcraft's situation in the days leading up to this dispatch, and Polishuk's report now puts a definitive cap on the conversation: the season is done, the arm is intact, and the focus shifts forward.

The numbers

Ashcraft's 2026 season line, per Polishuk's report: a 3.65 ERA over 165 1/3 innings, an All-Star selection, and a role as a key part of Pittsburgh's rotation. Those are the numbers of a pitcher who arrived and stayed. The innings total is notable — 165 1/3 is a meaningful workload for a pitcher in his first full season, and the arm fatigue at the end of it is less a surprise than a natural consequence of that kind of ramp-up.

Where the club stands

Pittsburgh is 79-77 (.506), third in the NL Central, 19 games back in the division, and ranked fifth in the Wild Card picture at 7.0 relative to the cut line. Both the division and Wild Card races are officially closed for the Pirates. The club enters the week on a four-game winning streak, which is the kind of late-season momentum that means something for a young roster even when the standings have already rendered a verdict.

Ashcraft won't be part of the final push, but the rotation still has work to do. Per the schedule, Jared Jones is lined up to start Tuesday, September 22 against the Cardinals at PNC Park, with Paul Skenes scheduled for Thursday, September 24 against St. Louis. Wednesday's probable starter is listed as TBD. Three games against the Cardinals to close out the home stand — not nothing, even in a season that has already decided its own ending.

What we don't know yet

The material does not address whether Ashcraft will require any further evaluation or treatment during the offseason, only that tests showed fatigue rather than structural damage. The timeline for his return to throwing is not specified in Polishuk's report. For Holderman, the key unknown is how he responds after resuming throwing on Monday — per the report, his availability for any late-season or postseason role remains uncertain. And for Brazoban, one scoreless inning is an encouraging data point, but whether it represents a turning point in his White Sox tenure or simply a good day is a question the remaining schedule will answer.

What to watch

Holderman's throwing session on Monday is the most time-sensitive item in this dispatch. If he comes through it cleanly, the conversation about his availability shifts from "if" to "when." If he does not, the Guardians will be navigating a division race with a hole in their bullpen that a first-round bye may or may not be enough to paper over. For Brazoban, the next few appearances will tell the White Sox — and anyone watching the AL Central — whether the version of him that showed up against the Tigers is the one they can count on down the stretch.